These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme. Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550 [TBL] [Abstract][Full Text] [Related]
6. Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance. Dubreucq S; Durand A; Matias I; Bénard G; Richard E; Soria-Gomez E; Glangetas C; Groc L; Wadleigh A; Massa F; Bartsch D; Marsicano G; Georges F; Chaouloff F Biol Psychiatry; 2013 May; 73(9):895-903. PubMed ID: 23237313 [TBL] [Abstract][Full Text] [Related]
7. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys. Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056 [TBL] [Abstract][Full Text] [Related]
8. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. Lawn W; Freeman TP; Pope RA; Joye A; Harvey L; Hindocha C; Mokrysz C; Moss A; Wall MB; Bloomfield MA; Das RK; Morgan CJ; Nutt DJ; Curran HV Psychopharmacology (Berl); 2016 Oct; 233(19-20):3537-52. PubMed ID: 27585792 [TBL] [Abstract][Full Text] [Related]
9. Differential glutamatergic and GABAergic contributions to the tetrad effects of Δ De Giacomo V; Ruehle S; Lutz B; Häring M; Remmers F Neuropharmacology; 2020 Nov; 179():108287. PubMed ID: 32860777 [TBL] [Abstract][Full Text] [Related]
10. Tetrahydrocannabinol (THC) Exacerbates Inflammatory Bowel Disease in Adolescent and Adult Female Rats. Dunford J; Lee AT; Morgan MM J Pain; 2021 Sep; 22(9):1040-1047. PubMed ID: 33727159 [TBL] [Abstract][Full Text] [Related]
11. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184. Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820 [TBL] [Abstract][Full Text] [Related]
12. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity. Katsidoni V; Kastellakis A; Panagis G Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148 [TBL] [Abstract][Full Text] [Related]
13. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Solinas M; Goldberg SR Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567 [TBL] [Abstract][Full Text] [Related]
16. A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Valjent E; Maldonado R Psychopharmacology (Berl); 2000 Jan; 147(4):436-8. PubMed ID: 10672638 [TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking. Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420 [TBL] [Abstract][Full Text] [Related]
18. Prior exposure to THC increases the addictive effects of nicotine in rats. Panlilio LV; Zanettini C; Barnes C; Solinas M; Goldberg SR Neuropsychopharmacology; 2013 Jun; 38(7):1198-208. PubMed ID: 23314220 [TBL] [Abstract][Full Text] [Related]
19. The ergogenic impact of the glucocorticoid prednisolone does not translate into increased running motivation in mice. Redon B; Violleau C; Georges F; Marsicano G; Chaouloff F Psychoneuroendocrinology; 2020 Jan; 111():104489. PubMed ID: 31706198 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid ligands and their effects on learning and performance in rhesus monkeys. Winsauer PJ; Lambert P; Moerschbaecher JM Behav Pharmacol; 1999 Sep; 10(5):497-511. PubMed ID: 10780256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]